{
    "2019-06-24": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Forget Bargain Hunting: Tap 5 Stocks With Rising P/E",
                "features": {
                    "keywords": [
                        "Bargain Hunting",
                        "Rising P/E"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "FDA lifts hold on one of AbbVie's trials of venetoclax",
                "features": {
                    "keywords": [
                        "FDA",
                        "lifts hold",
                        "AbbVie",
                        "venetoclax"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Announces US FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax in Patients with Multiple Myeloma Positive for the t(11;14) Genetic Abnormality",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "US FDA",
                        "Lifts Partial Clinical Hold",
                        "Venetoclax",
                        "Multiple Myeloma",
                        "t(11;14)"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}